Eton Pharmaceuticals Receives FDA Extension for NDA for ET-400On February 6, 2025, Eton Pharmaceuticals, Inc. announced through a press release that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) g
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Eton Pharmaceuticals’s 8K filing here. About Eton Pharmaceuticals (Get Free Report) Eton Pharmaceuticals, Inc, a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers […]
More Stories
Greenland Lawmakers Approve US, Denmark Security Deal
By Jill McLaughlin Greenland lawmakers unanimously approved a security agreement Nov. 3 with the United States and Denmark that will...
The World Looks Upside Down…But It Isn’t
By Louis Navellier The world seems to have been turned upside down, and we are suddenly all living in “Opposite...
US Oil Prices Fall More Than 7 Percent on Iran Peace Talks
By Andrew Moran Crude oil prices fell sharply to start the trading week on hopes of peace talks with Iran....
Appeals Court Allows Trump Admin Effort Targeting Noncitizen Voting
By Zachary Stieber A federal appeals court on Nov. 3 reinstated a decision that stays a restraining order that had...
US Manufacturing Expands for 10th Straight Month Amid High Input Costs
By Bill Pan U.S. manufacturing activity strengthened in October as new orders increased, although raw materials became more expensive and...
America Votes: What to Expect
By Lawrence Wilson Democrats appear poised to win control of the House and possibly the Senate on Nov. 3 as...